Top Markets
#1 Helium Helium +109.41%
#2 MowCat MowCat +103.90%
#3 Seeker Seeker +74.55%
#4 Pons Pons +47.43%
#5 AI XOVIA AI XOVIA +39.39%
#6 UnifAI Network UnifAI Network +33.34%
#7 Bounce Bounce +30.38%
#8 Tensor Tensor +22.88%
#9 Zylo Ecosystem Zylo Ecosystem +21.26%
#10 pipedog pipedog +20.42%
Coin of the day
Helium Helium
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Pozycja w akcjach #11443
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Cena akcji
$8.74
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$699.74M
Zmiana (1 dzień)
-4.85%
Zmiana (1 rok)
-2.29%
Kraj
US
Handel BridgeBio Oncology Therapeutics Inc. (BBOT)

Kategoria

Healthcare
Historia ceny akcji dla BridgeBio Oncology Therapeutics Inc. (BBOT)
Najwyższa cena zamknięcia: $9.16 dnia 2026-08-01

Najniższa cena zamknięcia: $10.40 dnia 2024-02-01
Historia cen akcji firmy BridgeBio Oncology Therapeutics Inc. od 2024 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -16.90%
2025 15.50%
2024 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH